Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kluth

Showing results (511-520 of 1,145) with videos related to

Pageof 115
Sort By:
Lung Cancer (Auckland, N.Z.)|January 14, 2026
Reduced Claudin-3 Expression Is Linked to Unfavorable Tumor Features and Poor Prognosis in Non-Small Cell Lung CancerNina Schraps, Martin Reck, Birgit Hantzsch-Kuhn, et al.
Urologia Internationalis|May 4, 2026
Structured Feedback Tools in Surgical Training: Results of the Endo-Workshop of the German Society of Residents in Urology 2024Julia C Kaulfuss, Luis A Kluth, Maximilian Reimann, et al.
International Journal of Cancer|October 12, 2020
Chromosome 5 harbors two independent deletion hotspots at 5q13 and 5q21 that characterize biologically different subsets of aggressive prostate cancerKatharina Möller, Martina Kluth, Malik Ahmed, et al.
BMC Cancer|July 24, 2015
The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletionChristoph Burdelski, Devi Menan, Maria Christina Tsourlakis, et al.
Journal for Immunotherapy of Cancer|November 9, 2019
Adoption of immunotherapy in the community for patients diagnosed with metastatic melanomaMarieke J Krimphove, Karl H Tully, David F Friedlander, et al.
Clinical Genitourinary Cancer|April 14, 2021
Salvage Radical Prostatectomy: Baseline Prostate Cancer Characteristics and Survival Across SEER RegistriesMike Wenzel, Christoph Würnschimmel, Luigi Nocera, et al.
Prostate Cancer and Prostatic Diseases|January 27, 2016
The prognostic role of preoperative serum C-reactive protein in predicting the biochemical recurrence in patients treated with radical prostatectomyS Sevcenco, R Mathieu, P Baltzer, et al.
The Prostate|July 27, 2021
Assessment of the optimal number of positive biopsy cores to discriminate between cancer-specific mortality in high-risk versus very high-risk prostate cancer patientsMike Wenzel, Christoph Würnschimmel, Francesco Chierigo, et al.
Urologic Oncology|February 19, 2020
MMR deficiency in urothelial carcinoma of the bladder presents with temporal and spatial homogeneity throughout the tumor massChristoph Fraune, Ronald Simon, Claudia Hube-Magg, et al.
Oncotarget|February 21, 2020
Prevalence and clinical significance of VHL mutations and 3p25 deletions in renal tumor subtypesFranziska Büscheck, Christoph Fraune, Ronald Simon, et al.
Pageof 115

Showing results (511-520 of 1,145) with videos related to

Sort By:
Pageof 115
Lung Cancer (Auckland, N.Z.)|January 14, 2026
Reduced Claudin-3 Expression Is Linked to Unfavorable Tumor Features and Poor Prognosis in Non-Small Cell Lung CancerNina Schraps, Martin Reck, Birgit Hantzsch-Kuhn, et al.
Urologia Internationalis|May 4, 2026
Structured Feedback Tools in Surgical Training: Results of the Endo-Workshop of the German Society of Residents in Urology 2024Julia C Kaulfuss, Luis A Kluth, Maximilian Reimann, et al.
International Journal of Cancer|October 12, 2020
Chromosome 5 harbors two independent deletion hotspots at 5q13 and 5q21 that characterize biologically different subsets of aggressive prostate cancerKatharina Möller, Martina Kluth, Malik Ahmed, et al.
BMC Cancer|July 24, 2015
The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletionChristoph Burdelski, Devi Menan, Maria Christina Tsourlakis, et al.
Journal for Immunotherapy of Cancer|November 9, 2019
Adoption of immunotherapy in the community for patients diagnosed with metastatic melanomaMarieke J Krimphove, Karl H Tully, David F Friedlander, et al.
Clinical Genitourinary Cancer|April 14, 2021
Salvage Radical Prostatectomy: Baseline Prostate Cancer Characteristics and Survival Across SEER RegistriesMike Wenzel, Christoph Würnschimmel, Luigi Nocera, et al.
Prostate Cancer and Prostatic Diseases|January 27, 2016
The prognostic role of preoperative serum C-reactive protein in predicting the biochemical recurrence in patients treated with radical prostatectomyS Sevcenco, R Mathieu, P Baltzer, et al.
The Prostate|July 27, 2021
Assessment of the optimal number of positive biopsy cores to discriminate between cancer-specific mortality in high-risk versus very high-risk prostate cancer patientsMike Wenzel, Christoph Würnschimmel, Francesco Chierigo, et al.
Urologic Oncology|February 19, 2020
MMR deficiency in urothelial carcinoma of the bladder presents with temporal and spatial homogeneity throughout the tumor massChristoph Fraune, Ronald Simon, Claudia Hube-Magg, et al.
Oncotarget|February 21, 2020
Prevalence and clinical significance of VHL mutations and 3p25 deletions in renal tumor subtypesFranziska Büscheck, Christoph Fraune, Ronald Simon, et al.
Pageof 115